Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

Kids as young as 6 years old could soon be allowed access to a weight loss drug, similar to Ozempic, to help reduce obesity.

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6-11, according to research presented Sept. 10 at a medical conference and published in the New England ...